Jane Street Group, LLC Adaptive Biotechnologies Corp Transaction History

Jane Street Group, LLC

$445 Billion
Q3 2024

A detailed history of Jane Street Group, LLC transactions in Adaptive Biotechnologies Corp stock. As of the latest transaction made, Jane Street Group, LLC holds 504,277 shares of ADPT stock, worth $2.23 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

504,277

Previous 1,021,533 50.64%

Holding current value

$2.23 Million

Previous $3.7 Million 30.19%

% of portfolio

0.0%

Previous 0.0%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.37 - $5.12 $1.74 Million - $2.65 Million	-517,256 Reduced 50.64%	504,277 $2.58 Million
Q2 2024 Aug 14, 2024	BUY	$2.34 - $3.96 $2.16 Million - $3.66 Million	923,848 Added 945.74%	1,021,533 $3.7 Million
Q1 2024 May 15, 2024	SELL	$2.88 - $4.8 $226,209 - $377,016	-78,545 Reduced 44.57%	97,685 $313,000
Q4 2023 Feb 14, 2024	BUY	$3.46 - $5.33 $499,153 - $768,927	144,264 Added 451.3%	176,230 $863,000
Q3 2023 Nov 14, 2023	SELL	$5.07 - $8.44 $242,974 - $404,478	-47,924 Reduced 59.99%	31,966 $174,000
Q2 2023 Aug 14, 2023	BUY	$6.19 - $8.78 $259,367 - $367,890	41,901 Added 110.3%	79,890 $536,000
Q1 2023 May 15, 2023	SELL	$7.8 - $10.11 $240,762 - $312,065	-30,867 Reduced 44.83%	37,989 $335,000
Q4 2022 Feb 14, 2023	BUY	$6.26 - $9.34 $319,554 - $476,778	51,047 Added 286.64%	68,856 $526,000
Q3 2022 Nov 14, 2022	BUY	$6.5 - $12.67 $115,758 - $225,640	17,809 New	17,809 $127,000
Q2 2022 Aug 16, 2022	SELL	$6.4 - $14.73 $1.46 Million - $3.37 Million	-228,889 Closed	0 $0
Q1 2022 May 17, 2022	BUY	$10.12 - $28.9 $2.13 Million - $6.08 Million	210,530 Added 1146.74%	228,889 $3.18 Million
Q4 2021 Feb 15, 2022	SELL	$25.17 - $36.85 $268,941 - $393,742	-10,685 Reduced 36.79%	18,359 $516,000
Q3 2021 Nov 16, 2021	BUY	$30.02 - $39.87 $523,879 - $695,771	17,451 Added 150.53%	29,044 $987,000
Q2 2021 Aug 16, 2021	SELL	$32.22 - $44.59 $1.29 Million - $1.78 Million	-40,019 Reduced 77.54%	11,593 $473,000
Q1 2021 May 18, 2021	BUY	$37.26 - $67.74 $1.53 Million - $2.79 Million	41,144 Added 393.05%	51,612 $2.08 Million
Q4 2020 Feb 17, 2021	SELL	$45.01 - $65.47 $1.93 Million - $2.8 Million	-42,789 Reduced 80.34%	10,468 $619,000
Q3 2020 Nov 17, 2020	BUY	$35.79 - $48.81 $1.15 Million - $1.57 Million	32,229 Added 153.27%	53,257 $2.59 Million
Q2 2020 Aug 17, 2020	BUY	$24.95 - $48.38 $252,793 - $490,186	10,132 Added 92.99%	21,028 $1.02 Million
Q1 2020 May 15, 2020	BUY	$16.96 - $34.16 $184,796 - $372,207	10,896 New	10,896 $303,000

Others Institutions Holding ADPT

# of Institutions

201

Shares Held

146M

Call Options Held

68.8K

Put Options Held

42.5K

View Full List

About Adaptive Biotechnologies Corp

Ticker ADPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 142,872,992
Market Cap $631M
Description
Adaptive Biotechnologies Corporation, a commercial-stage company, develops an immune medicine platform for the diagnosis and treatment of various diseases. The company offers immunoSEQ, a platform and core immunosequencing product that is used to answer translational research questions, as well as to discover new prognostic and diagnostic signal...

More about ADPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Adaptive Biotechnologies Corp Transaction History